Sep 6, 2024 · Patented technology drives molecular diagnostics for detection of viral and bacterial infections and antibiotic resistance markers.

SpeeDx is an Australian-based private company with offices in London and the US and distributors across Europe.

Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx employs a growing number of team members across our …

PlexZyme® is a patented detection technology allowing reliable multiplexing in qPCR testing without loss of sensitivity.

Combined test for detection of Mycoplasma genitalium and macrolide antibiotic resistance biomarkers from swab or urine specimens.

SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management.

Europe – SpeeDx Ltd. Acre House 11/15 William Road London, NW1 3ER, United Kingdom

Automation Improve productivity and streamline laboratory workflow with SpeeDx automation solutions. Flexible operation and programming for sample extraction preparation and/or qPCR reaction set-up. …

Triage seasonal respiratory testing with PlexPCR® Flu/RSV/SARS-CoV-2 Infections caused by Flu A, Flu B, RSV (A & B), and SARS-CoV-2 can all present with similar clinical symptoms. Adopt …

Combined test for detection of Neisseria gonorrhoeae and macrolide antibiotic resistance biomarkers from swab or urine specimens.